激活STING可以改善T细胞参与的免疫疗法,用于治疗急性髓性白血病
Andreas Linder1,2, Daniel Nixdorf3,4, Niklas Kuhl1
1Gene Center and Department of Biochemistry, Ludwig Maximilian University of Munich, Munich, Germany.
Blood
|February 26, 2025
概括
将一种STING激动剂与一种向CD33的双特异抗体 (BsAb) 结合起来,显著提高了它对急性髓性白血病 (AML) 的有效性. 这种方法可以促进T细胞活动和AML细胞的杀死,为AML治疗提供了一个有前途的新策略.
科学领域:
- 免疫学 免疫学 免疫学
- 在瘤学瘤学.
- 药理学 药理学是指药理学的学科.
背景情况:
- 针对CD33的双特异性抗体 (BsAbs) 在复发性/耐药性急性髓性白血病 (AML) 中表现有前途.
- 临床试验表明,在AML治疗中需要改善持久反应.
- 通过干扰素基因刺激器 (STING) 激活先天免疫系统是一种潜在的治疗途径.
研究的目的:
- 调查STING激活是否可以增强针对CD33的BsAb (AMG 330) 对AML的疗效.
- 阐明STING激动剂和AMG 330的协同作用背后的机制.
- 探索将STING激动剂与向CD33的BsAbs结合起来,以改善AML治疗的潜力.
主要方法:
- 在体外细胞毒性测定使用AML细胞系和初级AML细胞.
- 转录组分析和CRISPR-Cas9淘汰屏幕以确定分子机制.
- 免疫血栓检测以评估蛋白质水平的变化.
- 使用异种移植的AML模型进行体内研究.
主要成果:
- 刺痛激动剂 (cGAMP,diABZI) 显著增强了AMG 330介导的针对AML细胞的细胞毒性.
- 在AML细胞系和初级患者细胞中观察到协同效应.
- 通过IFN-γ和TNF激活的T细胞,增加了AML细胞对STING激活的敏感性.
- 激活STING导致增强I型IFN的产生和IFN刺激的基因诱导,与T细胞建立了积极的反循环.
结论:
- 将STING激动剂与向CD33的BsAbs结合起来,是一种强有力的策略,可以增强抗AML免疫反应.
- 在AML中,IFN-γ在调解BsAb有效性和STING通路激活方面发挥着关键作用.
- 这种联合治疗有望克服AML当前BsAb治疗的局限性.
相关概念视频
Tumor Immunotherapy
462
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
462
T Cell Activation and Clonal Selection
625
T cells are integral to our adaptive immune system, recognizing and effectively responding to foreign antigens. T cell activation and clonal selection are pivotal in orchestrating this immune response. This article elucidates these mechanisms, detailing the roles of cluster of differentiation (CD) markers, major histocompatibility complex (MHC) molecules, costimulatory signals, and the process of clonal selection.
Naive T cells that have not yet encountered an antigen express two primary CD...
Naive T cells that have not yet encountered an antigen express two primary CD...
625
Stem Cell Therapy for Tissue Regeneration
4.0K
Stem cell therapy is a method used in regenerative medicine to repair and restore function to damaged tissues and organs. Stem cells have the potential to proliferate and differentiate into various tissue types, making them ideal candidates for tissue regeneration. For example, hematopoietic stem cell transplants are commonly used in blood cancer treatment to replenish damaged bone marrow and restore healthy blood cells.
Types of Stem Cells used in Stem Cell Therapy
The two main cell...
Types of Stem Cells used in Stem Cell Therapy
The two main cell...
4.0K
Targeted Cancer Therapies
7.4K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.4K


